$NPHC Cashflow Statement | Understand Stock

$NPHC

$0.00 +$0.00 (0.0%) Close

$NPHC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Bad debt expense (recovery) - related party
Accrued interest expense for amount due to officer
Change in reserve for supplier advances for purchases
Bad debt expense - related party
Gain on sale of equipment
Net gain on settlement of debt, accrued expense and vendor payable
Change in allowance for credit losses
Depreciation
Stock-based compensation
Stock-based loan modification cost
Amortization of convertible notes receivable discount
Forgiveness of PPP loan
Change in fair value of convertible notes and derivatives
Amortization of notes receivables
Amortization of operating lease right-of-use assets
Changes in operating assets and liabilities:
Increase in accounts receivable
Increase in accounts receivable - related party
Increase in accounts receivable - related party, net
Decrease in inventory
Increase in other receivable
Increase in prepaid expenses and other current assets
Increase in accounts payable
Increase in accrued expenses
Increase in accrued payroll due to officers
Increase in deferred revenue - a related party
Decrease in deferred revenue - related party
Increase in accrued interest to related parties
Decrease in operating lease obligations
Decrease in security deposit

Net cash used in operating activities
Cash flows from investing activities:
Sale of Stemsation stock
Purchase of property and equipment
Convertible notes receivable advances
Convertible notes receivable repayments
Proceeds from sale of equipment
Net cash (used in) provided by investing activities
Cash flows from financing activities:
Loans from officer
Repayment of officer loans
Purchased a convertible note
Repayment of convertible notes
Advances from other notes payable
Repayments of other notes payable
Net cash provided by financing activities
Net change in cash
Cash - beginning of period
Cash - end of period
Supplemental Cash Flow Information:
Cash paid for interest
Non Cash Financing and Investing:
Common stock issued in settlement of notes
Common stock to be issued for stock based compensation
Common stock issued for debt modification and penalty
Common stock issued for conversion of debt
Common stock issued to satisfy accured interest-related party
Preferred stock issued to satisfy accrued salary
Increase of right-of-use asset due to lease renewal
Increase of operating lease liabilities due to lease renewal
Debt instrument increase accrued interest
Warrants issued with Debt--Debt discount
Increase in right-of-use assets and operating lease liabilities due to lease renewal
Common stock issued for settlement of vendor payable
Reclassification of convertible notes payable to due to officers
Reclassification of other receivable to convertible notes receivable
Related party debt forgiveness
Sale of Stemsation shares for which proceeds were receivable at period end
Stemsation shares awarded but not yet issued in settlement of convertible notes receivable
Stemsation shares received in settlement of convertible notes receivable

Comments